Glenmark Life Sciences informs about monitoring agency report

13 May 2022 Evaluate

Pursuant to Regulation 32(6) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 read with Regulation 41(4) of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, Glenmark Life Sciences has informed that it enclosing Monitoring Agency Report issued by HDFC Bank, Monitoring Agency, for the quarter ended 31st March, 2022 in respect of utilization of proceeds of the IPO of the Company.

The above information is a part of company’s filings submitted to BSE.

Alivus Life Sciences Share Price

907.15 1.75 (0.19%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×